Suplatast tosilate inhibits eosinophil production and recruitment into the skin in murine contact sensitivity

Clinical Immunology

Volumn 108, Issue 3, 2003, Pages 257-262

  Satoh, Takahiro ^a   Sasaki, Go ^a   Wu, Ming Hua ^a   Yokozeki, Hiroo ^a   Katayama, Ichiro ^b   Nishioka, Kiyoshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antiallergic agents; Contact sensitivity; Eotaxin; IL 4; IL 5

Indexed keywords

AZELASTINE; EMEDASTINE; EOTAXIN; INTERLEUKIN 4; INTERLEUKIN 5; PICRYL CHLORIDE; SUPLATAST TOSYLATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MATURATION; CONTACT SENSITIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; EDEMA; EOSINOPHIL; EOSINOPHILIA; LYMPH NODE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TH2 CELL;

EID: 0141453836     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6616(03)00154-2     Document Type: Article

References (21)

1. Satoh T., Chen Q.-J., Sasaki G., Yokozeki H., Katayama I., Nishioka K. Cyclophosphamide-induced blood and tissue eosinophilia in contact sensitivity mechanism of hapten-induced eosinophil recruitment into the skin . Eur. J. Immunol. 27:1997;85-91.
2. Sasaki G., Satoh T., Yokozeki H., Katayama I., Nishioka K. Regulation of cyclophosphamide-induced eosinophilia in contact sensitivity functional roles of interleukin-5-producing CD4+ lymphocytes . Cell. Immunol. 203:2000;124-133.
3. Yanagihara Y., Kiniwa M., Ikizawa K., Yamaya H., Shida T., Matsuura N., Koda A. Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent (1) regulation of immune IgE response . Jpn. J. Pharmacol. 61:1993;23-30.
4. K. Yamashita, S. Nakano, M. Kuwata, H. Yada, K. Irimura, H. Morinaga, K. Morita, Single dose toxicity studies of suplatast tosilate (IPD-1151T).
5. Schroeder J.-M., Mochizuki M. The role of chemokines in cutaneous allergic inflammation. J. Biol. Chem. 380:1999;889-896.
6. Asano K., Mizutani T., Shimane T., Hisano M., Hisamitsu T., Suzaki H. The inhibitory effect of anti-allergic agent suplatast tosilate (IPD-1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice. Mediators Inflamm. 9:2000;77-84.
7. Gautam S.C., Chikkala N.F., Hamilton T.A. Anti-inflammatory action of IL-4. J. Immunol. 148:1992;1411-1415.
8. Asada H., Linton J., Katz S.I. Cytokine gene expression during elicitation phase of contact sensitivity regulation by endogenous IL-4 . J. Invest. Dermatol. 108:1997;406-411.
9. Xu H., Dilulio N.A., Fairchild R.I. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production interferon-γ-producing (Tc1) effector CD8+ T cells and interleukin (IL)-4/IL-10-producing (Th2) negative regulatory CD4+ T cells . J. Exp. Med. 183:1996;1001-1012.
10. Steinbrink K., Sorg C., Macher E. Low dose tolerance to contact allergens in mice a functional role for CD8+ T helper type 2 cells . J. Exp. Med. 183:1996;759-768.
11. Yokozeki H., Ghoreishi M., Takagawa S., Takayama K., Satoh T., Katayama I., Nishioka K. Signal transducer and activator of transcription 6 is essential in the induction of contact sensitivity. J. Exp. Med. 191:2000;995-1004.
12. Satoh T., Yokozeki H., Nishioka K. Pathogenic roles of eosinophils in uinea-pig contact sensitivity regulation of dermal eosinophilia with remotely administered IL-5 . Clin. Exp. Immunol. 122:2000;300-307.
13. Yao L., Pan J., Setiadi H., Patel K.D., McEver R.P. Interleukin-4 or oncostatin M induces a prolonged increase in P-selectin mRNA and protein in human endothelial cells. J. Exp. Med. 184:1996;81-92.
14. Schleimer R.P., Sterbinski S.A., Kaiser J., Bickel C.A., Klunk D.A., Tomioka K., Newmwn W., Luscinskas F.W., Gimbrone M.A., McIntyre B.W. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium association with expression of VCAM-1 . J. Immunol. 148:1992;1086-1092.
15. Suwaki T., Agrawal D.K., Townley R.G. Modification of eosinophil function by suplatast tosilate (IPD), a novel anti-allergic drug. Int. Immunopharmacol. 1:2001;211163-211171.
16. Jutel M., Watanabe T., Klunker S., Akdis M., Thomet O.A.R., Malolepszy J., Zak-Nejmark T., Koga R., Kobayashi T., Blaser K., Akdis C.A. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature. 413:2001;420-424.
17. Caron G., Delneste Y., Roelandts E., Duez C., Bonnefoy J.-Y., Pestel J., Jeannin P. Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J. Immunol. 167:2001;3682-3686.
18. Saito T., Hagihara A., Igarashi N., Matsuda N., Yamashita A., Ito K., Mio M., Tasaka K. Inhibitory effect of emedastine difumarate on histamine release. Jpn. J. Pharmacol. 62:1993;137-143.
19. Saito H., Yamamoto N., Tomita S., Taniguchi M., Hasegawa M., Akiyama K., Kawaguchi H., Takahashi K. Effect of emedastine difumarate on CC chemokine-elicited eosinophil migration. Int. Arch. Allergy Immunol. 125:(Suppl. 1):2001;22-28.
20. Katayama S., Akimoto N., Shionoya H., Morimoto T., Katoh Y. Anti-allergic effect of azelastine hydrochloride on immediate type hypersensitivity reactions in vivo and in vitro. Arzneim.-Forschung. 31:1981;1196-1203.
21. Okada C., Eda R., Miyagawa H., Sugiyama H., Hopp R.J., Bewtra A.K., Townley R.G. Effect of cetrizine on human eosinophil superoxide generation, eosinophil chemotaxis and eosinophil peroxidase in vitro. Int. Arch. Allergy Immunol. 103:1994;384-390.